Codeine in Sickle Cell Disease
NCT00174538 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2011-06-30
Summary
The objective of this study is to determine if a subject's genetic make-up would affect the treatment response to codeine in subjects with sickle cell disease.
Conditions
Interventions
- DRUG
-
Codeine (30 mg)
Sponsors & Collaborators
-
PriCara, Unit of Ortho-McNeil, Inc.
lead INDUSTRY
Principal Investigators
-
Stacy S. Shord, PharmD · University of Illinois at Chicago
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-03-31
- Completion
- 2005-12-31
Countries
- United States
Study Locations
More Related Trials
-
Genetics and Pain Severity in Sickle Cell Disease
NCT01441141 ·Status: COMPLETED
-
Pain in Sickle Cell Epidemiologic Study
NCT00035763 ·Status: COMPLETED
-
Neurovascular Determinants of Cognitive Function in Adults With Sickle Cell Disease
NCT02946905 ·Status: COMPLETED
-
PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease
NCT00343954 ·Status: UNKNOWN ·Phase: PHASE1
-
Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease
NCT03978156 ·Status: TERMINATED ·Phase: PHASE1
-
Use of a Mobile-based App for SCD Patients
NCT01833702 ·Status: COMPLETED
-
Sickle Cell Disease (SCD) Bone Pain Study
NCT05283148 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell Anemia
NCT00001716 ·Status: COMPLETED ·Phase: PHASE2
-
Sickle Cell Trait in Football Players
NCT01891877 ·Status: UNKNOWN
-
Dose-Escalation Study of SCD-101 in Sickle Cell Disease
NCT02380079 ·Status: UNKNOWN ·Phase: PHASE1
-
Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease
NCT00252122 ·Status: TERMINATED ·Phase: PHASE4
-
Intranasal Fentanyl Versus Intravenous Morphine in the Treatment of Severe Painful Sickle Cell Crises in Children
NCT03682211 ·Status: COMPLETED ·Phase: PHASE4
-
Minocycline In Neurocognitive Outcomes - Sickle Cell Disease
NCT05605366 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Patients With Acute Sickle Cell Crises?
NCT03541980 ·Status: COMPLETED ·Phase: PHASE4
-
Feasibility of a Stress Reduction Intervention Study in Sickle Cell Disease
NCT02501447 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability and Pharmacokinetics of FTX-6058
NCT04586985 ·Status: COMPLETED ·Phase: PHASE1
-
Cognitive Behavioral Therapy and Real-Time Pain Management Intervention for Sickle Cell Via Mobile Applications
NCT04419168 ·Status: COMPLETED ·Phase: NA
-
Low Dose Ketamine and Acute Pain Crisis
NCT04330183 ·Status: COMPLETED ·Phase: PHASE4
-
Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain
NCT05519111 ·Status: RECRUITING ·Phase: PHASE2
-
Effectiveness of Arginine as a Treatment for Sickle Cell Anemia
NCT00513617 ·Status: COMPLETED ·Phase: PHASE2
-
Neuropsychological Studies of Children With Sickle Cell
NCT00005438 ·Status: COMPLETED
-
TRF-1101 Assessment in Sickle Cell Disease
NCT00773890 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Blood Sampling for Research Related to Sickle Cell Disease
NCT00542230 ·Status: RECRUITING
-
Pathophysiology of Acute Pain in Patients With Sickle Cell Disease
NCT03049475 ·Status: COMPLETED
-
Blood Flow and Pain Crises in People With Sickle Cell Disease
NCT01568710 ·Status: COMPLETED